ABSTRACT. SMAP2 is an Arf GTPase-activating protein that is located and functions on early endosome membranes. In the present study, the trans-Golgi network (TGN) was verified as an additional site of SMAP2 localization based on its co-localization with various TGN-marker proteins. Mutation of specific stretches of basic amino acid residues abolished the TGN-localization of SMAP2. Over-expression of wild-type SMAP2, but not of the mutated SMAP2, inhibited the transport of vesicular stomatitis virus-G protein from the TGN to the plasma membrane. In contrast, this transport was enhanced in SMAP2 (-/-) cells characterized by increased levels of the activated form of Arf. SMAP2 therefore belongs to an ArfGAP subtype that resides on the TGN and functions as a negative regulator of vesicle budding from the organelle.
Introduction
Arf proteins, which belong to the Ras superfamily of GTPbinding proteins, encode a small molecular weight GTPase and are found in all eukaryotic cells. Similar to other small GTPases, Arf molecules shuttle between activated GTPbound and inactivated GDP-bound forms. The exchange between GDP and GTP is catalyzed by an Arf-specific guanine nucleotide-exchanging factor (GEF) and a GTPaseactivating protein (GAP). Six Arfs (Arf1 to Arf6) and several Arf-related proteins have been identified in mammals (Donaldson and Jackson, 2000; D'Souza-Schorey and Chavrier, 2006; Gillingham and Munro, 2007; Nie et al., 2003) . Among the six Arf members, Arf1 and Arf6 are the most intensively studied and they are both involved in vesicle formation from donor membranes. Vesicles carrying membrane proteins are transported to appropriate acceptor organelles. Arf1 regulates vesicle transport between/within the endoplasmic reticulum, Golgi apparatus and early endosomes, whereas Arf6 is involved in the regulation of endocytosis of plasma membrane proteins and the recycling of proteins to the cell membrane (Donaldson, 2005; Kahn, 2009) .
Vesicle formation is an elaborate and complex multi-step process mediated by Arf, ArfGEFs, ArfGAPs, coatomer and cargo proteins that act at distinct steps and have specific roles in the process. The initial step involves the activation of Arf by an Arf-specific GEF and the binding of the activated Arf-GTP to the membrane. The activated Arf recruits coatomer proteins and phosphatidyl inositol (PI) kinase to the membrane. The activation of different PI kinases generates distinct species of PI-phosphate that facilitate the assembly of the coatomer protein complex and vesicle budding. ArfGAP can function as an effector for activated Arf, thus contributing to the selection and loading of adequate cargo protein onto vesicles. Finally, ArfGAP catalyzes the hydrolysis of Arf-bound GTP to yield inactive Arf-GDP, which is accompanied by the dissociation of Arf from the coatomer complex and its association with cargo, leading to vesicle budding (East and Kahn, 2011; Spang et al., 2010) .
We previously reported the identification of an ArfGAP subtype called SMAP2 that contains an ArfGAP domain in its amino-terminus and regulates Arf1 . SMAP2 harbors clathrin-and clathrin assembly protein (CALM)-binding motifs/domains, which might contribute to the formation of clathrin-coated membrane vesicles. Furthermore, SMAP2 co-localizes with the clathrinadaptor proteins AP-1 and epsinR, and is located on early endosomes. SMAP2 overexpression caused a delay in the accumulation of the TGN38/46 protein and suggested that SMAP2 regulates the retrograde transport of proteins from early endosomes to the trans-Golgi network (TGN). SMAP1, a homologue of SMAP2, targets Arf6 and binds to clathrin, regulating the clathrin-dependent endocytosis of the transferrin receptor and E-cadherin molecules Tanabe et al., 2005 Tanabe et al., , 2008 .
SMAP genes have been identified from yeast to mammals . In yeast, age2 is a SMAP homologue that is involved in the transport of clathrin-coated vesicles between plasma membrane, endosomes and TGN (Poon et al., 2001; Wong et al., 2005) . Furthermore, the ArfGAP protein Nevershed, a SMAP homologue in Arabidopsis, is located and functions at multiple sites such as the plasma membrane, endosomes and the TGN (Liljegren et al., 2009) . The SMAP gene appears to have been duplicated into SMAP1 and SMAP2 during the evolution of vertebrates and each SMAP may play a unique role in vesicle formation and transport. In the present study, the localization of the SMAP2 protein on the TGN and its possible involvement in the anterograde transport of vesicles from the TGN were examined.
Materials and Methods

Cells
COS7 and HeLa cells were cultured in DMEM containing 10% (v/v) fetal bovine serum. COS1 cells stably expressing the exogenously introduced galactosyl transferase fusion protein (GAL-T) and green fluorescent protein (GFP) were used (Misaki et al., 2007) . Murine embryonic fibroblasts (MEF) were prepared according to a previously described method (Nakayama et al., 1996) . Briefly, murine embryos were taken at embryonic day 16.5 and digested by trypsin. Single suspension cells were cultured in a monolayer in DMEM supplemented with serum for 3 days, and immortalized by transfection with the SV40-derived large T antigen to establish permanent cell cultures. Embryos were taken from pregnant mice generated by mating SMAP2 (+/-) mice with each other. Generation and genotyping of SMAP2-targeted mice will be described in detail elsewhere (unpublished observation, MS).
Antibodies
The antibodies used in the present study and the companies from which they were purchased are as follows: anti-influenza hemagglutinin (HA) rat monoclonal antibody (mAb) was from Roche Diagnostics (Indianapolis, IN); anti-Arf mouse mAb was from Affinity BioReagents (Golden, CO); anti-AP-1 (γ-adaptin), antiGolgi 58 kDa mouse mAbs and anti-SMAP2 rabbit polyclonal antibody (pAb) were from Sigma-Aldrich (St. Louis, MO); anti-TGN46 sheep pAb was from Serotec (Oxford, United Kingdom); anti-calnexin and anti-GM130 mouse mAbs were from Transduction laboratories (Lexington, KY); Cy3-conjugated goat anti-rat IgG was from Chemicon (Temecula, CA); and Alexa488-conjugated goat anti-mouse and anti-rabbit IgGs, and Alexa488-conjugated donkey anti-sheep IgGs were from Molecular Probes (Eugene, OR). Anti-SMAP2 rabbit pAb prepared by our group was used for immunoblot analyses, whereas anti-SMAP2 pAb purchased from Sigma-Aldrich was used for immunofluorescence detection.
Plasmid DNA and retrovirus
A cDNA encoding murine SMAP2 was inserted into a mammalian expression vector, pcDNA3 (Invitrogen, Carlsbad, CA). For immunodetection, the SMAP2 protein was tagged at its amino-terminus, thus generating HA-SMAP2. A cDNA encoding the PH domain of FAPP1 (four-phosphate-adaptor protein 1) was amplified by PCR using the primers 5'-GAAGATCTATGGAGGGGGTTCTGTAC-AAG-3' and 5'-CGGAATTCTTAAGTCCTCGTGTCGGTCA-AAC-3', and inserted into a pEGFP-C1 vector (Clontech, Palo Alto, CA), resulting in the EGFP-FAPP1-PH construct. The various mutations described below were introduced into the coding region of SMAP2 or FAPP1 by PCR. A cDNA encoding a temperature sensitive (ts) mutant of vesicular stomatitis virus glycoprotein (VSV-G) and fused at its carboxy-terminus to EGFP (Kasai et al., 1999) was provided by K. Nakayama. The chimeric cDNA was inserted into pcDNA3 or a retrovirus vector, pMX-puro (Onishi et al., 1996) . A stock solution of retrovirus was prepared by transfecting plasmid DNA of pMX-puro-VSV-G-GFP into PLAT-E cells as described previously (Ishikawa et al., 2008) .
Immunofluorescence microscopy
Immunofluorescence detection procedures were performed according to the method described previously (Tanabe et al., 2005) . Briefly, cells were transfected with 100 ng of SMAP2-expressing plasmid DNA using Effectene (QIAGEN, Chatsworth, CA) and incubated for 16 h at 37°C. Cells were fixed with 4% (w/v) paraformaldehyde in phosphate buffered saline. Primary and secondary antibodies were used in the combinations indicated for indirect immunofluorescence. Images were visualized by confocal microscopy with an LSM-510 (Zeiss, Thornwood, NY) and immunofluorescence microscopy with a BZ8100 (Keyence, Chicago, Il). To measure fluorescence intensity, the LSM5 Image Examiner tool was used.
Measurement of VSV-G transport from the TGN
COS7 cells were transfected with the pcDNA3-VSV-G-GFP plasmid and MEF cells were infected by retrovirus harboring pMXpuro-VSV-G-GFP. After incubation at 40°C for 24 h, the cells were placed at 20°C for 1 h and then at 32°C for 1, 2 or 2.5 h. Cycloheximide (100 μg/ml) was added to the medium at the last hour at 40°C and through the 20°C to 32°C incubations. The cells were fixed and processed for detection of immunofluorescence.
GST-pull down and immunoblot analyses
A chimeric cDNA construct encoding glutathione S-transferase (GST) fused to the GAT domain of GGA3 and generated as described previously (Takatsu et al., 2002) was provided by K. Nakayama. This plasmid was inserted into a bacterial expression vector, pGEX-4T-2 (Amersham Pharmacia, Biotech, Piscataway, NJ). The E. coli strain BL21 was transformed with this plasmid and grown. Induction and purification of recombinant protein (GST-GGA3 in this case) were performed as described previously (Tanabe et al., 2005) .
MEF cells were lysed in a buffer containing 50 mM Tris-HCl (pH 8.0), 1% (v/v) TritonX-100, 150 mM KCl, 2 mM MgCl2, 10% (v/v) glycerol, 1 mM DTT, 1 mM EGTA, 1 mM EDTA, and a mixture of protease inhibitors (Complete; Roche Diagnostics). The lysates were pre-cleared by incubating with glutathionecoupled agarose beads (Pierce Chemical, Rockford, IL), and then processed for pull down assay using GST or GST-GGA3 as adsorbents. Five μg of GST or GST-GGA3 protein were mixed with glutathione-agarose beads, the mixture was rotated for 10 min, and the beads were recovered by centrifugation at 5000 rpm for 2 min. The cell lysates prepared as above were incubated with beadsbound GST or GST-GGA3 proteins for 2 h at 4°C, and the mixture was wash-centrifuged five times with lysis buffer. The beadsbound protein fractions were finally recovered by boiling the beads in SDS sample buffer.
The protein fraction pulled down as above or the cell lysate itself prior to pull down were subjected to immunoblot analyses following previously described procedures (Tanabe et al., 2005) .
Results
SMAP2 localization to the TGN
Transfection of HA-tagged SMAP2 cDNA into COS7 cells and immunofluorescence staining of HA resulted in two distinct staining patterns (see Fig. 1 , left panels), namely multiple fluorescent dots scattered in the cytoplasm, and a perinuclear crescent-shaped fluorescent signal. Prior colocalization studies with several early endosome markers indicated that the multiple dot pattern represents localization to early endosomes . In a previous study, we simultaneously observed a perinuclear crescent signal; however, we did not investigate this signal because we wanted to concentrate our efforts on analyzing the multiple dot pattern. In the present study, we have investigated the perinuclear localization of SMAP2 thoroughly. Double-staining of cDNA-transfected cells with anti-TGN-marker and anti-HA antibodies revealed that the SMAP2-derived crescent-shaped fluorescence co-localized with TGN46, a representative marker of the TGN (first row of Fig. 1 . For a 3D-projected view of SMAP2 and TGN46, see Supplementary Fig. 1 ). The PH domain of FAPP1 binds specifically to phosphatidyl inositol 4-phosphate (PI4P) (Dowler et al., 2000) , and PI4P is highly concentrated near the TGN. The PH domain of FAPP1 can therefore be used for the detection of PI4P and as an indirect marker of TGN localization. In the present study, the SMAP2 fluorescence signal overlapped the signal from the PH domain ( Fig. 1 , second row). The binding of FAPP1-PH to PI4P is abolished by the R18L mutation. The present results showed that the R18L-mutated PH domain did not localize to the TGN but was rather distributed throughout the cytoplasm and did not co-localize with SMAP2 fluorescence (Fig. 1 , third row). GAL-T, which is known to be located in the TGN (Roth and Berger, 1982) , was fused to GFP and stably transduced into COS1 cells (Misaki et al., 2007) . Transfection of SMAP2 into COS1-GAL-T-GFP cells caused the overlapping of fluorescence from SMAP2 and GAL-T-GFP (Fig. 1, fourth row) . The SMAP2 fluorescent signal in COS7 cells did not overlap with that from calnexin, a marker of the endoplasmic reticulum (Fig. 1, fifth row) . The results shown in Fig. 1 suggest that the perinuclear crescent shaped SMAP2 signal indicates the localization of SMAP2 to the TGN. Introduction of SMAP2 cDNA into HeLa cells gave essentially the same results, showing the TGN localization of SMAP2 ( Supplementary Fig. 2) .
As a caveat, we note that perinuclear SMAP2 apparently co-localized with GM130, a marker of cis-Golgi in COS7 cells ( Fig. 2A) . We therefore examined whether SMAP2 localized to cis-Golgi by incubating cells with brefeldin A (Fig. 2B ). Drug treatment dispersed GM130 but not TGN46 staining, indicating that the integrity of the cis-Golgi but not the TGN is sensitive to this drug (first row in Fig. 2B ). Under this condition, SMAP2 still co-localized with TGN46 (second row) but the signal did not overlap anymore with GM130 (third row). The findings strengthen the conjecture that SMAP2 is localized to the TGN but not to cis-Golgi. The apparent co-localization of SMAP2 and GM130 in Fig. 2A is probably due to the limited resolution of the microscope employed.
A basic amino acid stretch is necessary for the TGN localization of SMAP2
The results described above suggested the existence of an amino acid (aa) sequence responsible for the TGN localization of SMAP2. To examine this possibility, mutations were introduced into the SMAP2 protein as shown in Fig. 3 . Fig. 1 . Subcellular localization of SMAP2 protein by immunofluorescence detection. First and fifth rows: COS7 cells were transfected with HA-tagged SMAP2-cDNA and processed for double immunofluorescence using anti-HA and anti-TGN46 or anti-calnexin antibodies. Second and third rows: COS7 cells were co-transfected with HA-SMAP2 and a vector harboring the PH domain (or its R18L mutant) derived from FAPP1. This PH domain was fused to EGFP. SMAP2 was detected by anti-HA antibody, whereas PH was detected as EGFP-derived fluorescence. Fourth row: COS1 cells stably expressing exogenously introduced GAL-T were transfected with HA-SMAP2. GAL-T was fused to GFP, and GFP-derived fluorescence was detected.
Mutation 1 (M1) corresponds to an R56Q replacement in the zinc finger domain that abolishes the ArfGAP activity of the protein. M2 harbors mutations in a stretch of basic aa residues (KYEKKK) in the ArfGAP domain. This basic aa stretch was chosen because it could serve as a phospholipidinteracting motif based on its positive charge. The KEKDDK sequence chosen in M3 has a highly hydrophilic nature. The LLGLD and DLL clathrin-binding motifs mutated in M4 have been shown to cause loss of the clathrin-binding activity of SMAP2 . M5 and M6 harbor mutations in the SILSLY stretch and CALM-binding region, respectively. The SILSLY stretch is evolutionarily conserved in almost all of the SMAP family proteins (unpublished observation, MS), although its significance is not known. In M2 through to M6, the corresponding aa stretches were replaced by alanine residues.
Transfection of M1, M3, M4, M5 and M6 into COS7 cells and immunofluorescence detection resulted in a similar subcellular localization as that found for wild-type SMAP2 (Fig. 4A) , showing both multiple dot and perinuclear crescent patterns. As for the perinuclear crescent pattern, the individual co-localizations of M1 and M4 with TGN46 were confirmed ( Supplementary Fig. 3, panel A) . In contrast, the SMAP2 fluorescent signal in the M2 mutant was restricted to the multiple dot fluorescence, as the perinuclear signal was not detected (Fig. 4B) . Therefore, fluorescence from endogenous TGN46 or GAL-T corresponding to the TGN did not overlap with M2 fluorescence. We confirmed in Supplementary Fig. 3, Over-expression of SMAP2 suppresses the transport of VSV-G from the TGN To examine the possible role of TGN-localized SMAP2 on cargo transport from the TGN, the ts-mutant VSV-G protein (Polishchuk et al., 2003; Presley et al., 1997) was used. The cDNA of GFP-fused VSV-G was transfected into COS7 cells. Incubation of cells at 40°C caused the detection of fluorescence derived from unfolded VSV-G on the endoplasmic reticulum (Fig. 5A, left panel) . Incubation of cells at the non-permissive 20°C allowed the transport of de novo synthesized VSV-G from the endoplasmic reticulum to the TGN, but not from the TGN, resulting in a high concentration of VSV-G fluorescence in the TGN (middle panel). A shift of temperature to the permissive 32°C for 2 h caused the release of VSV-G from the TGN and its transport to the cell surface (right panel). The findings described in Fig. 5A are in agreement with those of prior reports (Saitoh et al., 2009) .
The functional significance of the TGN-localization of SMAP2 was further examined by co-transfecting SMAP2 and VSV-G cDNAs (Fig. 5B ). Cells were incubated at various temperatures serially as indicated in panel A, fixed after the 2 h incubation at 32°C and processed for double immunofluorescence. In SMAP2-expressing cells, VSV-G was not distributed at the cell surface but remained on the TGN (Fig. 5B, first row) . SMAP2 fluorescence was detected on the TGN and in multiple early endosomes. However, in cells transfected with M2-mutated SMAP2, VSV-G did not accumulate on the TGN and was detected on the cell surface (Fig. 5B, second row) . The M2 protein retained fluorescence in the multiple dot pattern but lost it from the TGN. M1 and M4 mutant SMAP2 proteins were detected on the TGN, and in these mutant-expressing cells, VSV-G fluorescence remained on the TGN (Fig. 5B , third and fourth rows).
Quantification of fluorescence was carried out by measuring the VSV-G fluorescence intensity of the cell surface and the TGN in SMAP2 (or mutant)-positive cells. At least 200 individual cells were measured for each SMAP2 cDNAtransfection. The ratio of TGN-derived fluorescence intensity to cell-derived intensity was calculated and is shown in Fig. 6 as an average. Compared to un-transfected cells, this ratio was 2-fold higher in wild-type SMAP2-expressing cells (p<0.0001), which suggests that over-expression of SMAP2 blocked the transport of VSV-G from the TGN. The block in the TGN transport was also observed in cells transfected with M1-and M4-mutated SMAP2. Although M1 is devoid of ArfGAP activity, it retains the clathrinbinding motif, and its overexpression might alter clathrin function, thus inhibiting VSV-G transport. In contrast, the M2-mutation likely abrogated the SMAP2 ability to retain VSV-G on the TGN (a statistically significant difference was detected between the wild type SMAP2-and M2-transfected cells, but not between the un-transfected control and M2-transfected cells). The loss of TGN-localization of the M2 mutant suggests that SMAP2 localization to the TGN is necessary for its function in the inhibition of VSV-G transport.
SMAP2-deficient cells contain a higher level of activated Arf protein
The significance of endogenous SMAP2 in TGN transport was evaluated using SMAP2-deficient cells (the generation of SMAP2-targeted mice will be described elsewhere). Mouse embryonic fibroblasts (MEFs) were established from two independent cultures (numbers 1 and 2) of SMAP2 (-/-) and wild-type embryos. Protein extracts were prepared and processed for immunoblot analyses using an anti-SMAP2 antibody (Fig. 7A) . A band corresponding to the SMAP2 protein of the expected size (45 kDa) was detected in wildtype but not in SMAP2 (-/-) MEF extracts.
Expression of endogenous SMAP2 was also examined by immunofluorescence using an anti-SMAP2 antibody (Fig.  7B) , which confirmed the results of the immunoblot, showing positive fluorescence in the cytoplasm of wild-type but not SMAP2 (-/-) MEFs. Furthermore, fluorescence from the endogenous SMAP2 protein overlapped with the signal from the Golgi-58 kDa protein, which is a marker of trans-, medial and cis-Golgi networks (note that Golgi-58 kDa was similarly detected in both SMAP2 (+/+) and (-/-) MEFs (data not shown). In addition, fluorescence from endogenous SMAP2 substantially overlapped with that from AP-1 (data not shown). We also confirmed that, in COS7 and HeLa cells, fluorescence from endogenous SMAP2 co-localized with that from TGN46 and AP-1 each ( Supplementary  Fig. 4 ). These results indicate that endogenously expressed SMAP2 is located in the TGN.
GGA3 is a clathrin-adaptor protein that is recruited to activated (GTP-bound) Arf, and therefore the extent of Arf activation inside the cells can be estimated by measuring the amount of Arf that is bound to GGA3. Cell lysates were incubated with GST-GGA3 coupled glutathione-agarose, and the bound fraction was eluted and processed for immunoblot analyses (Fig. 7C) . The numbers below the gel and in the histograms represent the percentages of the amount of activated Arf relative to the total amount of Arf. The relative After incubation at 40°C for 24 h, the cells were placed at 20°C for 1 h and then at 32°C for 2 h. Cycloheximide (100 µg/ml) was added to the medium at the last hour of the 40°C incubation and through the 20°C and 32°C incubations. The cells were then fixed and processed for fluorescent detection of GFP. (B) COS7 cells were co-transfected with cDNA encoding SMAP2 or its mutated version and VSV-G-GFP, incubated as in (A), fixed after 2 h at 32°C, and processed for immunofluorescence detection of SMAP2 and VSV-G. SMAP2-positive cells are indicated by arrowheads. amount of activated Arf was increased by 4.0 fold in SMAP2 (-/-) MEF as compared to wild-type MEF cells. This observation is in agreement with our previous report showing that SMAP2 is an Arf1 GTPase-activating protein .
Transport of VSV-G from the TGN is enhanced in SMAP2-deficient cells
Because the transfection efficiency was low in MEFs, a retrovirus stock solution encoding the VSV-G-GFP fusion protein was prepared. Wild-type and SMAP2 (-/-) MEFs were infected with the virus and processed for immunofluorescence (Fig. 8A) . At 20°C, VSV-G was retained on the TGN (co-localization of VSV-G with TGN-located AP-1, data not shown), while the incubation of cells at 32°C for 2.5 h allowed the release of VSV-G from the TGN in both the wild-type and targeted MEFs. However, at 1 h after the temperature shift to 32°C, VSV-G was still on the TGN in wild-type MEFs, but already released in SMAP2 (-/-) MEFs.
To further examine the differences in TGN transport between wild-type and SMAP2 (-/-) MEFs, the fluorescence intensities of VSV-G were quantified as in Fig. 6 using MEF cells that were incubated at 32°C for 1 h. As seen in Fig. 8B , the ratios of TGN-derived to whole cell VSV-G fluorescence were decreased by one half to one third in SMAP2-deficient MEFs as compared to wild type (p<0.01). These results indicate that SMAP2-deficiency enhances the transport of VSV-G from the TGN.
Discussion
The present study demonstrated that SMAP2 is located on the TGN region, in addition to the previously reported localization to early endosomes. This conclusion is based on the co-localization of SMAP2 with TGN marker proteins such as TGN46, GAL-T and the PH domain of FAPP1. Mutations in SMAP2 revealed that the GAP and clathrin-binding activities of SMAP2 were not required for its localization to the TGN. The findings of the present study with SMAP2 are similar to those reported for its homolog SMAP1, in which GAP activity and clathrin-binding are not necessary for its localization to the plasma membrane and cytoplasm Tanabe et al., 2005) .
In the present study, the KYEKKK stretch located in the ArfGAP domain's carboxy-terminus was found to be important for the localization of SMAP2 to the TGN. However, this stretch is conserved in SMAP1 (see Supplementary Fig. 5 ), indicating that the motif by itself is not sufficient to direct SMAP2 to the TGN. Interestingly, the replacement of KYEKKK by alanine residues abolished the TGN-localization of SMAP2 but did not affect its early endosome localization. Therefore, different motifs may direct SMAP2 to TGN and early endosome membranes. The localization of clathrin-adaptor molecules such as AP-1 and GGA to the TGN is mediated by the high affinity of these molecules for PI4P, and basic motifs in AP-1 and GGA are responsible for binding to PI4P (Heldwein et al., 2004; Wang et al., 2003 Wang et al., , 2007 . We thus hypothesized that SMAP2 may directly bind to PI4P via its KYEKKK sequence. To examine this, a protein fragment of SMAP2 (aa 1-263) was prepared and processed for an in vitro lipid binding assay. The SMAP2 fragment did not bind to any type of PI including PI4P (unpublished observation, KT), suggesting that the TGN localization of SMAP2 does not involve its direct binding to a lipid component in the membrane.
An alternative explanation is that the KYEKKK in SMAP2 (but not that in SMAP1) may associate with an intermediate TGN-located molecule. Eps15 interacts with TGN-located AP-1 (Chi et al., 2008) , and Rab1 activates a TGN-located molecule, PI-4 kinase III α, producing a high amount of PI4P (Dumaresq-Doiron et al., 2010) . As a result, both Eps15 and PI4P-interacting GBF1 are retained on the TGN. ArfGAP2/3 contains K-rich stretches (see Supplementary Fig. 5 ) and binds to β-COP, which is located on the Golgi apparatus (Kliouchnikov et al., 2009) . Stonin 2 is a clathrin-adaptor molecule that harbors a KYE motif that is evolutionarily conserved in eukaryotes (see Supplementary Fig. 5 ). The KYE in stonin 2 is responsible for the binding to synaptotagmin (Diril et al., 2006) . The KYEKKK stretch of SMAP2 could be analogous to the K-rich stretch in ARfGAP2/3 and the KYE motif in stonin 2, and could interact with a putative TGN-localized protein to recruit SMAP2 to the TGN.
The significance of SMAP2 in the anterograde transport of vesicles from the TGN to plasma membranes was evaluated using the temperature sensitive VSV-G protein. Overexpression of wild-type as well as clathrin-binding-negative Wild-type and SMAP2 (-/-) MEF cells were processed for immunofluorescence detection using an anti-SMAP2 antibody. Nuclei were stained by DAPI and cells were doubly stained for SMAP2 and Golgi-58 kDa protein (anti-Golgi 58 kD was used, since antibody to TGN38, a mouse ortholog of human TGN46, did not work well in MEFs). (C) Pull down assay of GST-GGA3-bound activated Arf. Lysates prepared from wild-type or SMAP2 (-/-) cells were incubated with GST-GGA3-coupled glutathione agarose. The bound fractions were eluted and processed for immunoblot detection using an anti-Arf antibody (the pull-down fraction represents activated Arf). An aliquot of the lysates prior to pull down was also processed for immunoblot analysis ("total" represents the sum of active and inactive Arf). The numbers below the immunoblot image and in the histograms represent the percentages of the amounts of pulled-down Arf relative to the total amount of Arf. Experiments were performed three times independently, and one representative gel blot is shown. Histograms indicate averages and SD of the percentages. Asterisks indicate statistically significant differences between SMAP2 (+/+) and (-/ -) MEF cultures (p<0.05). mutant (M4) SMAP2 proteins impaired the transport of VSV-G from the TGN. These inhibitory effects are probably linked to the ArfGAP activity of these proteins as discussed below. Interestingly, the GAP-negative mutant SMAP2 protein (M1) also inhibited VSV-G transport. Although M1 is devoid of ArfGAP activity, it retains clathrin-and CALM-binding motifs; thus, its over-expression probably perturbs clathrin-related functions, thereby inhibiting VSV-G transport. In contrast, over-expression of the M2 mutant of SMAP2, which was characterized by the loss of TGNlocalization, did not result in a full inhibition of VSV-G trafficking away from the TGN. We also observed that the efficiency of VSV-G transport was significantly enhanced in SMAP2 (-/-) MEF cells. Fig. 8 . Effects of SMAP2-deficiency on VSV-G transport from the TGN. (A) Wild-type and SMAP2 (-/-) MEF cultures were infected by a retrovirus encoding VSV-G-GFP. The cells were incubated at 40°C for 24 h, at 20°C for 1 h, and at 32°C for 1 h and 2.5 h. Cycloheximide (100 µg/ml) was added to the medium at the last hour at 40°C and through the 20°C to 32°C incubations. The cells were fixed at the end of incubation at the indicated temperatures and VSV-G was visualized. (B) The cells were incubated at 40°C for 24 h, at 20°C for 1 h, and at 32°C for 1 h, and fixed. Fluorescence intensities were quantified as in Fig. 6 . The ratios of TGN-derived VSV-G fluorescence to whole cell fluorescence are shown for wild-type and SMAP2 (-/-) MEF cells. Asterisks indicate statistically significant differences (p<0.01).
These findings obtained from SMAP2 over-expression and deficiency suggest that SMAP2 might function as a negative regulator of the formation/transport of clathrincoated vesicles on/from TGN. This is compatible with a model in which GEF-mediated Arf activation facilitates vesicle formation, whereas inactivation of Arf by ArfGAP terminates this process. In this model, over-expression of SMAP2 would enhance the hydrolysis of Arf-GTP and inhibit vesicle formation. On the other hand, the absence of SMAP2 would result in the maintenance of Arf in its active GTP-bound state and the more efficient recruitment of clathrin adaptor molecules such as AP-1 and GGA, thereby leading to the enhancement of vesicle formation. In the present study, a substantial increase in the levels of the active form of Arf was observed in SMAP2 (-/-) MEF cells, which supports the model. Furthermore, another group recently examined the role of SMAP2 in the retrograde transport of Shiga-toxin from early endosomes to the TGN using siRNA against SMAP2 and reported an enhancement of transport efficiency in targeted cells .
The model proposed above is in opposition to the recently proposed and generally believed model of ArfGAP as a positive player in vesicle formation, which directly involves ArfGAP in cargo-selection (East and Kahn, 2011; Spang et al., 2010) . Therefore, the effects of ArfGAP targeting appear to be controversial in the literatures. Triple knock-down of ArfGAP1/2/3 inhibits the transport of VSV-G from the endoplasmic reticulum (Saitoh et al., 2009) . Retrograde transport of Shiga-toxin and anterograde transport of VSV-G between early endosomes and the TGN are inhibited in AGAP2-knock down cells but enhanced in GIT2-knock down cells . Knock down of ACAP1 delays recycling of integrin β1 and the transferrin receptor (Li et al., 2005) , whereas that of AMAP2 inhibits endocytosis of the IL-2 receptor (Hashimoto et al., 2004) . Finally, lysosome-targeting of the EGF receptor is increased in ARAP1-targeted cells (Yoon et al., 2008) . These observations collectively imply that the effects of ArfGAP knock down might differ depending on the ArfGAP isoform. ArfGAP may therefore have a positive or negative role in vesicle formation, which could vary between ArfGAP family members. Elucidation of the mechanisms mediating SMAP2 activity could therefore help define the role of ArfGAP in vesicle formation and transport.
